There are 18 papers on G8 score in aging research: 16 observational studies in people, 1 review.
18 papers study it91 more mention it15 findings
2 new papers in 30 daysSee all 109 papers on G8 score
“The frailty risk (G8 score) was not associated with 2-year OS.”
- Humans16
Effects
1Overall survival
no changein humans1
1 study
Overall survival
no changein humans1
G8 score showed no clear effect on overall survival in humans (older adults with head and neck cancer).
“The frailty risk (G8 score) was not associated with 2-year OS.”
Human trialolder adults with head and neck cancer2 yearsn = 475
European journal of cancer (Oxford, England : 1990)
Associations
10Mortality
downin humans3upin humans2HR 2.35–4.58
5 studies
Mortality
downin humans3upin humans2HR 2.35–4.58
G8 score predicts mortality in humans (solid tumors) (AUC 0.65, C-index 0.60).
“outperforming the G8 score (AUC 0.65; C-index 0.60) and Balducci's classification (AUC 0.58; C-index 0.56) (all pairwise p < 0.001).”
Humanssolid tumorsn = 822
Journal of geriatric oncology
G8 score predicts mortality in humans (newly diagnosed prostate cancer) (HR 2.9, 95% CI 1.8-4.5, AUC 0.715).
“Defining frailty as the presence of comorbidities (CCI ≥ 1 point) shows inferior (HR:1.3, 95% CI: 0.8-2.1-AUC: 0.583) accuracy compared to the G8-score (HR 2.9, 95% CI 1.8-4.5-AUC: 0.715).”
Humansnewly diagnosed prostate cancermalesn = 182
Clinical genitourinary cancer
G8 score predicts mortality in humans (univariate Cox model) (HR: 2.35, 95% CI 1.53-3.60, p < 0.001).
“for the G8-score (HR: 2.35, 95% CI 1.53-3.60, p < 0.001)”
Humansunivariate Cox modeln = 197
Cancers
G8 score predicts mortality in humans (mCRPC treated with ARPIs) (p < 0.001 and p = 0.004).
“independent prognostic factors for both worse rPFS and OS were Geriatric G8 assessment ≤ 14”
HumansmCRPC treated with ARPIsmalesn = 234
Current oncology (Toronto, Ont.)
G8 score predicts mortality in humans (endometrial cancer) (HR: 4.58; 95% CI [1.35-15.51]).
“only the G8 Score retained independent significance as a prognostic factor for disease-specific survival (DSS) (HR:4.58; 95% CI [1.35-15.51])”
Humansendometrial cancerfemalesn = 153
Journal of cancer research and clinical oncology
Handgrip strength
downin humans1
1 study
Handgrip strength
downin humans1
Handgrip strength is associated with G8 score in humans (hospitalized oncology patients; reduced handgrip strength) (p < 0.001).
“Reduced handgrip strength was associated with lower G8 scores (p < 0.001) and lower G8 item C mobility scores (p = 0.001).”
Humanshospitalized oncology patients; reduced handgrip strengthn = 116
Nutrients
Treatment side effects
mixedin humans1
1 study
Treatment side effects
mixedin humans1
G8 score is associated with treatment side effects in humans (Patients with hepatocellular carcinoma receiving sorafenib).
“Additionally, worse G8 scores were correlated with greater side effects after 3 months of treatment.”
HumansPatients with hepatocellular carcinoma receiving sorafenib3 months
European Journal of Geriatrics and Gerontology
Quality of life
mixedin humans1
1 study
Quality of life
mixedin humans1
G8 score is associated with quality of life in humans (Patients with hepatocellular carcinoma receiving sorafenib; most follow-up encounters).
“Moreover, lower G8 scores were significantly correlated with worse QoL subscale scores during most follow-up encounters.”
HumansPatients with hepatocellular carcinoma receiving sorafenib; most follow-up encounters3 months
European Journal of Geriatrics and Gerontology
Physical function
mixedin humans1
1 study
Physical function
mixedin humans1
G8 score is associated with physical function in humans (Patients with hepatocellular carcinoma receiving sorafenib).
“A worse G8 score was significantly associated with poorer physical function, as measured by TUGT, in all three encounters.”
HumansPatients with hepatocellular carcinoma receiving sorafenib3 months
European Journal of Geriatrics and Gerontology
Urinary continence recovery
upin humans1OR 1.56
1 study
Urinary continence recovery
upin humans1OR 1.56
G8 score predicts urinary continence recovery in humans after robot-assisted radical prostatectomy (OR 1.56, P < 0.05).
“Multivariable analysis showed age (3-month odds ratio (OR) 0.973, 1-year OR 0.947), nerve-sparing (3-month OR 2.39, 1-year OR 1.77), and low frailty (3-month OR 1.56, 1-year OR 1.75) as significant factors affecting continence recovery”
Humansafter robot-assisted radical prostatectomy3 monthsmalesn = 1,794
World journal of urology
Tokyo Metropolitan Institute of Gerontology Index of Competence
downin humans1
1 study
Tokyo Metropolitan Institute of Gerontology Index of Competence
downin humans1
G8 score is associated with Tokyo Metropolitan Institute of Gerontology Index of Competence in humans (stage 0-III NSCLC post-surgery).
“Conversely, a low G8 score was sole factor associated with a decline in the TMIG-IC score after 24 months.”
Humansstage 0-III NSCLC post-surgery24 monthsn = 876
Journal of geriatric oncology
More on Tokyo Metropolitan Institute of Gerontology Index of Competence
Lifespan
downin humans1HR 2.89
1 study
Lifespan
downin humans1HR 2.89
G8 score predicts lifespan in humans (endometrial cancer) (HR: 2.89; 95% CI [1.31-6.39]).
“overall survival (OS) (HR:2.89; 95% CI [1.31-6.39]”
Humansendometrial cancerfemalesn = 153
Journal of cancer research and clinical oncology
Charlson Comorbidity Index
upin humans1
1 study
Charlson Comorbidity Index
upin humans1
G8 score is associated with Charlson Comorbidity Index in humans (urological conditions) (p < 0.05).
“Both tests correlated significantly with the Charlson comorbidity index, length of stay, number of coded diagnosis, and Braden score (p < 0.05).”
Humansurological conditionsn = 100
Comparison of G8 and ISAR Screening Results in Geriatric Urology
Medicines (Basel, Switzerland)
ISAR score
downin humans1
1 study
ISAR score
downin humans1
G8 score is associated with ISAR score in humans (urological conditions) (r = -0.77, p < 0.001).
“There was a significant negative correlation between the G8 and ISAR scores (r = -0.77, p < 0.001).”
Humansurological conditionsn = 100
Comparison of G8 and ISAR Screening Results in Geriatric Urology
Medicines (Basel, Switzerland)